- $8.20m
- $6.94m
- $0.00m
Annual balance sheet for HeartSciences, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.723 | 0.918 | 1.66 | 5.81 | 1.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | 0.002 | 0 | — | 0.004 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.64 | 1.93 | 2.7 | 7.35 | 2.17 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.289 | 0.159 | 0.591 | 0.56 | 0.435 |
| Net Intangible Assets | |||||
| Total Assets | 1.93 | 2.09 | 3.29 | 9.5 | 4.22 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.25 | 3.47 | 1.83 | 1.75 | 3.7 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.84 | 8.15 | 3.06 | 2.19 | 4.02 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -1.91 | -6.06 | 0.231 | 7.32 | 0.205 |
| Total Liabilities & Shareholders' Equity | 1.93 | 2.09 | 3.29 | 9.5 | 4.22 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |